NPNeal S. Peachey

Neal S. Peachey

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Neal S. Peachey has a total of 368 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A multi-ancestry genome-wide association study of dry eye disease and systemic comorbidities

    by Bryan R. Gorman, Jaxon J. Huang, Peter B. Barr, Christopher W. Halladay, Cari L. Nealon, Chris Chatzinakos, Michael Francis, Chen Jiang, Paul B. Greenberg, Wen-Chih Wu, et al.

  • Open Access

    A Primary Open-Angle Glaucoma Locus Near Transcription Factor PRRX1 Identified in the Million Veteran Program

    by Tyler G. Kinzy, Osahon J. Asowata, Lauren A. Cruz, Andrea R. Waksmunski, Jingwen Cai, Puja Mehta, Sabrina L. Mitchell, Levi Svaren, Inas F. Aboobakar, Ayobami A. Alimi, et al.

  • Open Access

    Selective deletion of Slc2a1 from the RPE reveals that rods but not cones depend on glucose transport across the outer blood-retinal barrier

    by Lauren L. Daniele, John Y.S. Han, Minzhong Yu, Ravi A. Sangani, Craig D. Beight, Cyrus Rostami, Philip D. Kiser, Neal S. Peachey, Nancy J. Philp

  • Characterization of Hepatotropic Small Molecule Inhibitors of Hypoxia Inducible Factor Prolyl Hydroxylase in the Prevention of Oxygen-Induced Retinopathy

    by Christie Campla, George Hoppe, Minzhong Yu, Juliana Woda, Neal S. Peachey, Vara Prasad Josyula, Shaun R. Stauffer, Jonathan E. Sears

    Retinopathy of prematurity (ROP) blinds severely premature infants and is caused by oxygen supplementation. Hypoxia-inducible factor (HIF) stabilization during hyperoxia can prevent oxygen-induced retinopathy (OIR), the experimental correlate of ROP. Stabilization of hepatic HIF-1 alone can prevent OIR while contemporaneously protecting other organ systems, such as the lung and brain, from oxygen toxicity. However, HIF stabilization in central nervous system (CNS) oligodendrocytes reduces myelination. Here, we report the synthesis of small molecules specifically designed to not cross the blood-brain barrier based on a prodrug structure susceptible to hepatic carboxylesterases that release active drug. Twenty compounds were synthesized and rank ordered by Western blot, hypoxia response element binding, and reporter gene analysis. The lead compound prevented OIR, maintained normal CNS myelination, preserved the electroretinogram b-wave, and protected astrocytes. Strategies such as this might be broadly applicable to target specific hepatic functions while limiting off-target effects in other organs.

  • Open Access

    Rare genetic variation in PTPRB is associated with central serous chorioretinopathy, varicose veins and glaucoma

    by Joel T. Rämö, Bryan R. Gorman, Lu-Chen Weng, Sean J. Jurgens, Panisa Singhanetr, Marisa G. Tieger, Elon Hc van Dijk, Christopher W. Halladay, Xin Wang, Blake M. Hauser, et al.

    Central serous chorioretinopathy is an eye disease characterized by fluid buildup under the central retina whose etiology is not well understood. Abnormal choroidal veins in central serous chorioretinopathy patients have been shown to have similarities with varicose veins. To identify potential mechanisms, we analyzed genotype data from 1,477 patients and 455,449 controls in FinnGen. We identified an association for a low-frequency (allele frequency = 0.5%) missense variant (rs113791087) in PTPRB, the gene encoding vascular endothelial protein tyrosine phosphatase (odds ratio=2.85, P = 4.5 × 10-9). This was confirmed in a meta-analysis of 2,452 patients and 865,767 controls from 4 studies (odds ratio=3.06, P = 7.4 × 10-15). Rs113791087 was associated with a 56% higher prevalence of retinal abnormalities (35.3% vs 22.6%, P = 8.0 × 10-4) in 708 UK Biobank participants and, surprisingly, with increased risk of varicose veins (odds ratio=1.31, P = 2.3 × 10-11) and reduced risk of glaucoma (odds ratio=0.82, P = 6.9 × 10-9). Predicted loss-of-function variants in PTPRB, though rare in number, were associated with central serous chorioretinopathy in All of Us (odds ratio=17.09, P = 0.018). These findings highlight the significance of vascular endothelial protein tyrosine phosphatase in diverse ocular and systemic veno-vascular diseases.


  • Open Access

    Genome-wide association study of dry eye disease reveals shared heritability with systemic comorbidities

    by Bryan R. Gorman, Jaxon J. Huang, Peter B. Barr, Christopher W. Halladay, Cari L. Nealon, Chris Chatzinakos, Michael Francis, Chen Jiang, Million Veteran Program, Paul B. Greenberg, et al.

    Dry eye disease (DED) affects up to 25% of the adult population, with chronic symptoms of pain and dryness often negatively impacting quality of life. The genetic architecture of DED is largely unknown. Here, we develop and validate an algorithm for DED in the Million Veteran Program using a combination of diagnosis codes and prescription records, resulting in 132,657 cases and 352,201 controls. In a multi-ancestry genome-wide association study, we identify ten significant loci in nine susceptibility regions with largely consistent effects across ancestries, including loci linked to synapse maintenance ( EPHA5 , GRIA1 , SYNGAP1 ) and autoimmunity ( BLK ). Phenome-wide scans for genetic pleiotropy indicate substantial genetic correlations of DED with comorbidities, including fibromyalgia, post-traumatic stress disorder, and Sjögren’s disease. Finally, applying genomic structural equation modeling, we derive a latent factor underlying DED and other chronic pain traits which accounts for 51% of the genetic variance of DED.


  • Open Access

    In vivo exchange of glucose and lactate between photoreceptors and the retinal pigment epithelium

    by Daniel T Hass, Elizabeth Giering, John Ys Han, Celia M Bisbach, Kriti Pandey, Brian M Robbings, Thomas O Mundinger, Nicholas D Nolan, Stephen H Tsang, Neal S Peachey, et al.

    Photoreceptors in the retina of a vertebrate’s eye are supported by a tissue adjacent to the retina, the retinal pigment epithelium (RPE). The RPE delivers glucose to the outer retina, consumes photoreceptor outer segments discs, and regenerates 11-cis-retinal. Here we address the question of whether photoreceptors also provide metabolic support to the RPE. We use complementary approaches and animal models to show that glucose is the primary fuel for the retina, that photoreceptors are the primary cell type in the retina to consume glucose, and that lactate derived from photoreceptor glucose consumption is transported to and catabolized by the RPE. These data rigorously support and extend the concept of a metabolic ecosystem between photoreceptors and RPE.


  • Top Cited Papers

    Genome-wide association analyses identify distinct genetic architectures for age-related macular degeneration across ancestries

    by Bryan R. Gorman, Georgios Voloudakis, Robert P. Igo, Tyler Kinzy, Christopher W. Halladay, Tim B. Bigdeli, Biao Zeng, Sanan Venkatesh, Jessica N. Cooke Bailey, Dana C. Crawford, et al.

    To effectively reduce vision loss due to age-related macular generation (AMD) on a global scale, knowledge of its genetic architecture in diverse populations is necessary. A critical element, AMD risk profiles in African and Hispanic/Latino ancestries, remains largely unknown. We combined data in the Million Veteran Program with five other cohorts to conduct the first multi-ancestry genome-wide association study of AMD and discovered 63 loci (30 novel). We observe marked cross-ancestry heterogeneity at major risk loci, especially in African-ancestry populations which demonstrate a primary signal in a major histocompatibility complex class II haplotype and reduced risk at the established CFH and ARMS2/HTRA1 loci. Dissecting local ancestry in admixed individuals, we find significantly smaller marginal effect sizes for CFH risk alleles in African ancestry haplotypes. Broadening efforts to include ancestrally distinct populations helped uncover genes and pathways that boost risk in an ancestry-dependent manner and are potential targets for corrective therapies.


  • Adaptive selection at G6PD and disparities in diabetes complications

    by Joseph H. Breeyear, Jacklyn N. Hellwege, Philip H. Schroeder, John S. House, Hannah M. Poisner, Sabrina L. Mitchell, Brian Charest, Anjali Khakharia, Til B. Basnet, Christopher W. Halladay, et al.

    Diabetes complications occur at higher rates in individuals of African ancestry. Glucose-6-phosphate dehydrogenase deficiency (G6PDdef), common in some African populations, confers malaria resistance, and reduces hemoglobin A1c (HbA1c) levels by shortening erythrocyte lifespan. In a combined-ancestry genome-wide association study of diabetic retinopathy, we identified nine loci including a G6PDdef causal variant, rs1050828-T (Val98Met), which was also associated with increased risk of other diabetes complications. The effect of rs1050828-T on retinopathy was fully mediated by glucose levels. In the years preceding diabetes diagnosis and insulin prescription, glucose levels were significantly higher and HbA1c significantly lower in those with versus without G6PDdef. In the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, participants with G6PDdef had significantly higher hazards of incident retinopathy and neuropathy. At the same HbA1c levels, G6PDdef participants in both ACCORD and the Million Veteran Program had significantly increased risk of retinopathy. We estimate that 12% and 9% of diabetic retinopathy and neuropathy cases, respectively, in participants of African ancestry are due to this exposure. Across continentally defined ancestral populations, the differences in frequency of rs1050828-T and other G6PDdef alleles contribute to disparities in diabetes complications. Diabetes management guided by glucose or potentially genotype-adjusted HbA1c levels could lead to more timely diagnoses and appropriate intensification of therapy, decreasing the risk of diabetes complications in patients with G6PDdef alleles.


  • Open Access

    Multi-ancestry genome-wide association meta-analysis of mosaic loss of chromosome Y in the Million Veteran Program identifies 240 novel loci

    by Michael Francis, Bryan R. Gorman, Tim B. Bigdeli, Giulio Genovese, Georgios Voloudakis, Jaroslav Bendl, Biao Zeng, Sanan Venkatesh, Chris Chatzinakos, Gabriel Hoffman, et al.

    Mosaic loss of chromosome Y (mLOY) is the most commonly detected mosaic chromosomal alteration, and is associated with a range of health outcomes in males. We detected mLOY in 106,054 European (EUR), 13,927 admixed African (AFR), and 6,127 Hispanic (HIS) participants of the Million Veteran Program (MVP; Ntotal=544,112). mLOY was positively associated with cigarette smoking, and negatively with obesity and type 2 diabetes. Multi-ancestry genome-wide association meta-analysis of MVP and UK Biobank mLOY summary statistics, jointly comprising 167,899 cases and 581,224 controls, identified 380 independent risk loci—240 of which were novel. GWAS in MVP high cell fraction (CF>10%) mLOY cases exhibited stronger effect sizes across risk loci. Local-ancestry-aware GWAS resolved ancestry-specific signals at BCL2L1 and SETBP1. Integrative eQTL analyses highlighted 51 genes that causally influence mLOY via differential expression. Finally, traits with genetic correlations and polygenic scores significantly associated with mLOY were selected for Mendelian randomization (MR), implicating thirteen traits as causal influences on mLOY, including triglycerides, high-density lipoprotein, and body mass index.